| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Nutex Health Inc. Common Stock
$191.5
+3.03 (+1.61%)
Market Cap
1.32 B
EPS
26.15
P/E Ratio
7.29 $
Value Trade
71.92 M
14.55 %
Week
18.08 %
1 Month
50.86 %
3 Month
88.17 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
-
Monthly Burn
-
Runway
-
Overview
Volume
26.69 K
52 Week Range
77.21 - 204
% held by Insiders
32.71 %
% held by Institutions
42.92 %
Enterprise Value
1.15 B
Total Shares
6.88 M
Short %
25.23 %
Float Shares
4.38 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
NUTX Clinical Trial Results & History
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in NUTX
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
NUTX Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-NUTX
Aug 18, 2026▲ +1.6%today
NUTEX HEALTH OPENS WEST LITTLE ROCK EMERGENCY HOSPITAL IN ARKANSAS
Nutex Health Inc. has opened the West Little Rock Emergency Hospital, its 28th facility nationwide and third in Arkansas. The new hospital features advanced medical technology, including MRI and CT imaging, and offers 24/7 care. This facility aims to improve healthcare accessibility for families in Central Arkansas.
Read more →-NUTX
Aug 6, 2026▲ +6.7%on this news· ran to +30% by day 1
NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
Nutex Health Inc. reported strong financial results for Q2 2026, with net income rising to $65.8 million and EBITDA reaching $94.1 million. Despite a 6.3% decrease in total revenue year-over-year, the company demonstrated improved operational efficiency and cash flow. The CFO expressed confidence in the company's growth trajectory, supported by upcoming hospital openings.
Read more →-NUTX
Jul 21, 2026Nutex Health Schedules 2026 Second Quarter Financial Results Release and Conference Call
Nutex Health, Inc. plans to release its second quarter financial results for 2026 on August 6, followed by a conference call on August 7 at 9:30 a.m. CT. The call will provide insights into the company's financial performance and business updates. Nutex operates 27 micro hospitals across 12 states, emphasizing its integrated healthcare delivery system.
Read more →-NUTX
Apr 30, 2026▲ +17.1%on this news
NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Nutex Health Inc. reported its financial results for Q1 2026, showing a 2.2% increase in total revenue to $216.5 million and a significant rise in net income to $46.8 million. The company also highlighted a strong operating cash flow of $75.5 million and plans to open three new hospitals later this year. The financial performance underscores Nutex's effective growth strategy and operational improvements.
Read more →-NUTX
Apr 30, 2026▲ +6.4%on this news· ran to +25% by day 1shared move
Document NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS HOUSTON, TX (PRNewswire) - APRIL 30, 2026 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ NUTX), today announced financial results for the
Nutex Health Inc. reported its financial results for the first quarter of 2026, highlighting a revenue increase of 2.2% year-over-year to $216.5 million, driven mainly by growth in its hospital division. The company's net income attributable to shareholders surged by 120.6% to $46.8 million, reflecting effective operational strategies and cash generation. Nutex Health is also seeing an increase in total visits, and it plans to open three new hospital facilities this year, aiming for sustained growth.
Read more →-NUTX
Apr 22, 2026Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call
Nutex Health, Inc. plans to release its first quarter financial results for 2026 on April 30, 2026, followed by a conference call on May 1, 2026, at 9:30 a.m. CT. The call will provide insights into the company's financial performance and business updates. Nutex operates a network of micro hospitals and physician groups across 12 states.
Read more →-NUTX
Mar 5, 2026▼ -14.3%on this news
NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM
Nutex Health Inc. reported strong financial results for 2025, with total revenue reaching $875.3 million, an 82.4% increase from 2024. The company also announced a second stock repurchase program of up to $25 million. Despite a significant drop in fourth quarter revenue due to arbitration claims, the overall performance reflects robust growth and operational improvements. The company continues to expand its services with new micro-hospitals.
Read more →-NUTX
Mar 5, 2026Document NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM FULL YEAR 2025 HIGHLIGHTS Total revenue of $875.3 million for the year 2025 versus $479.9 million for the year 2024, an i
Nutex Health announced significant financial results for 2025, reporting total revenue of $875.3 million, up 82.4% from 2024, and net income of $70.8 million. Key highlights include a diluted EPS increase to $10.48 and a substantial rise in adjusted EBITDA to $259.6 million, reflecting strong operational growth. However, the company faced challenges in Q4 2025, with a revenue decline of 41.1%, attributed mainly to arbitration-related adjustments. CEO Tom Vo emphasized the firm's robust growth strategy and the opening of new facilities, alongside corrective measures for previously disclosed financial control weaknesses.
Read more →-NUTX
Feb 25, 2026▲ +6.7%on this news
Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call
Nutex Health, Inc. plans to file its Annual Report for the fiscal year ending December 31, 2025, on March 5, 2026. An earnings conference call is scheduled for March 6, 2026, at 9:30 a.m. CT to discuss financial results and provide a business update. The company operates 27 micro hospitals and outpatient departments across 12 states.
Read more →-NUTX
Jan 12, 2026NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON
Nutex Health Inc. has reopened Bayou City ER & Hospital in Humble, Texas, offering 24/7 concierge-level care. The facility includes advanced imaging technology and a full-service laboratory, aiming to meet the growing healthcare needs of the Northeast Houston community. Leadership emphasizes the importance of specialized services for unique patient needs.
Read more →-NUTX
Jan 5, 2026▲ +13.1%on this news· ran to +24% by day 3
NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO
Nutex Health Inc. announced its participation in the 2026 J.P. Morgan Healthcare Conference, scheduled for January 12-15 in San Francisco. CEO Dr. Tom Vo, CFO Jon Bates, and President Dr. Warren Hosseinion will represent the company. The event highlights Nutex's integrated healthcare delivery system and its commitment to innovation in healthcare.
Read more →-NUTX
Dec 22, 2025NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS
Nutex Health Inc. has opened its 26th hospital, Archview ER & Hospital, in St. Louis, Missouri. The facility features 15 emergency room beds and advanced imaging technology, offering 24/7 care to the community. The hospital aims to provide exceptional healthcare and is strategically located near significant landmarks, symbolizing innovation and accessibility.
Read more →-NUTX
Dec 4, 2025▲ +19%on this news
NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN
Nutex Health Inc. has announced an extension of its stock repurchase program, initially set to expire in December 2025, now extended through March 31, 2026. The program aims to repurchase up to $25 million of its common stock to enhance shareholder value and offset dilution from stock compensation obligations. This decision reflects the Board's confidence in the company's long-term strategy.
Read more →-NUTX
Nov 26, 2025NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT
Nutex Health Inc. has responded to a short seller report from Capybara Research, which it claims lacks credibility. The company asserts that the report's allegations are based on outdated and inaccurate information. Nutex Health emphasizes its operational structure and ongoing legal disclosures while declining to comment further on the report.
Read more →-NUTX
Nov 24, 2025▼ -13.1%on this newsshared move
NUTEX HEALTH REOPENS RED RIVER ER & HOSPITAL IN TEXAS
Nutex Health Inc. has announced the reopening of the Red River ER & Hospital in Sherman, Texas. The facility offers advanced medical services, including emergency care and imaging technology. With a focus on community health, the hospital aims to provide 24/7 concierge-level care. This reopening marks a significant milestone for Nutex Health's mission to enhance healthcare delivery in the region.
Read more →-NUTX
Nov 19, 2025▲ +26.9%on this newsshared move
NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Nutex Health Inc. reported substantial financial growth for the third quarter and year-to-date results for 2025. Total revenue reached $723.6 million, a 225.5% increase compared to the same period in 2024, while net income surged to $59.0 million from a loss of $9.5 million. The company also reported significant improvements in EBITDA and adjusted EBITDA, reflecting strong operational performance. Additionally, Nutex regained compliance with Nasdaq listing requirements.
Read more →-NUTX
Nov 19, 2025▲ +13.1%on this news· ran to +43% by day 1shared move
Document NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024,
Nutex Health reported exceptional financial results for the third quarter and year-to-date ending September 30, 2025. The company achieved total revenue of $723.6 million for the first nine months, a remarkable increase of 225.5% compared to the prior year. Net income turned from a loss of $9.5 million to a profit of $59.0 million, showcasing a substantial operational improvement. Notably, adjusted EBITDA surged to $243.0 million, indicating strong profitability amidst robust growth in its micro hospital and outpatient services.
Read more →-NUTX
Nov 18, 2025▲ +13.1%on this news· ran to +43% by day 1shared move
NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
Nutex Health Inc. reported substantial financial growth for the first half of 2025, with total revenue rising to $455.8 million, a 217.5% increase from the previous year. The company achieved a net income of $3.5 million, contrasting with a net loss in the same period of 2024. Despite a significant rise in stock-based compensation expenses, adjusted EBITDA reached $144.4 million, reflecting strong operational performance. The company also announced a stock repurchase program to enhance shareholder value.
Read more →-NUTX
Nov 18, 2025▲ +13.1%on this news· ran to +43% by day 1shared move
NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS
Nutex Health Inc. reported restated financial results for Q1 2025, showing a remarkable increase in total revenue to $211.8 million, up 214% from the previous year. The company achieved a net income of $21.2 million, a significant turnaround from a net loss in Q1 2024. EBITDA also saw a substantial rise of 624.7%. However, the restatement was necessary due to accounting adjustments, including changes in stock-based compensation classifications.
Read more →-NUTX
Nov 18, 2025▲ +13.1%on this news· ran to +43% by day 1shared move
NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS
Nutex Health Inc. reported its restated financial results for 2024, showcasing a remarkable revenue growth of 93.8% to $479.9 million and a net income of $52.1 million, reversing a loss from the previous year. The company also highlighted a substantial increase in adjusted EBITDA, reflecting strong operational performance. However, restatements resulted in a decrease in total equity and increased liabilities.
Read more →-NUTX
Nov 18, 2025Document NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS FULL YEAR 2024 HIGHLIGHTS Total revenue of $479.9 million for the year 2024 versus $247.6 million for the year 2023, an increase of 93.8% Net income attributa
Nutex Health reported restated financial results for the year 2024, revealing significant growth with total revenue up 93.8% to $479.9 million and net income of $52.1 million, recovering from a loss in the prior year. The adjustments included reclassifications in financial statements, resulting in a slight increase in liabilities and a small decrease in equity. Notably, EBITDA and adjusted EBITDA showed marked improvements, reinforcing the company's financial strength, despite the challenges posed by a substantial increase in stock-based compensation expenses. The company expresses confidence in its growth strategy and plans to utilize a stock repurchase program to enhance shareholder returns.
Read more →-NUTX
Nov 18, 2025Document NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS Total revenue of $211.8 million for Q1 2025 versus $67.5 million for Q1 2024, an increase of 214.0% Net income attributable to Nutex Health Inc.
Nutex Health Inc. reported substantial financial growth for Q1 2025, with a revenue increase to $211.8 million from $67.5 million in Q1 2024. The net income for the period reached $21.2 million, marking a recovery from a net loss of $0.4 million the previous year. Adjusted EBITDA also saw significant gains, moving from a loss to $72.8 million. The company cited successful arbitration efforts with insurance carriers as contributing factors to its improved financial metrics.
Read more →-NUTX
Nov 18, 2025Document NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS Total revenue of $455.8 million for the first half of 2025 versus $143.5 million for the first half of 2024, an increase of 21
Nutex Health reported significant financial growth for the first half of 2025, with total revenue increasing by 217.5% to $455.8 million. The company flipped from a net loss in the prior year to a net income of $3.5 million, while EBITDA also saw substantial growth. Despite high stock-based compensation expenses and a quarterly net loss attributed to these costs, Nutex announced a stock repurchase program to boost shareholder confidence. The financial results reflect a strong recovery and ongoing growth strategy in the healthcare sector.
Read more →-NUTX
Oct 20, 2025▲ +17%on this news
NUTEX HEALTH PROVIDES CORPORATE UPDATE
Nutex Health Inc. reported significant growth in patient volume and cash collections for Q3 2025, with an 11.1% increase in patient visits and a remarkable 258.8% rise in cash collections compared to the same quarter last year. The company is addressing accounting errors that have delayed financial filings and received a non-compliance notice from Nasdaq. Nutex is actively working to regain compliance and finalize its financial statements.
Read more →-NUTX
Oct 6, 2025Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3
Nutex Health Inc. announced that its hospitals earned a record 20 awards in Q3 2025, marking the highest recognition in the company's history. The awards, voted on by the community, highlight the hospitals' commitment to superior patient care and satisfaction. This achievement underscores Nutex Health's integrated healthcare delivery system and its focus on quality service.
Read more →-NUTX
Sep 30, 2025Document NUTEX HEALTH PROVIDES CORPORATE UPDATE Significant Year-over-Year Growth in Patient Volume and Cash Collections HOUSTON, TX (PRNewswire) - OCTOBER 20, 2025 - Nutex Health Inc. ("Nutex Health" or the "Company") (
Nutex Health Inc. reported a substantial increase in both patient volume and cash collections for the third quarter of 2025, marking a growth of 11.1% and 258.8%, respectively, compared to the same quarter in 2024. The company attributes this growth to strategic expansions and an improved revenue cycle management. However, Nutex is currently facing challenges due to errors in previously issued financial statements that have led to delays in filing required reports with Nasdaq. The company has submitted a plan to regain compliance and is working to finalize its financial documentation.
Read more →-NUTX
Sep 22, 2025NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER
Nutex Health Inc. has appointed Wesley Bamburg as its new Chief Operating Officer, effective October 13, 2025. Bamburg, who has extensive experience in healthcare operations, previously served as COO at HCA Houston Healthcare North Cypress. His appointment is seen as a strategic move to support Nutex Health's growth and commitment to patient-centric care.
Read more →-NUTX
Sep 22, 2025Forward-Looking Statements Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. When used i
Nutex Health Inc. has announced the appointment of Wesley Bamburg as its new Chief Operating Officer, effective October 13, 2025. Bamburg brings 20 years of experience in healthcare operations and has previously held COO positions at HCA Healthcare facilities. His leadership is expected to enhance Nutex Health's operations and contribute to the company's ongoing growth and commitment to patient-centered care. The announcement reflects the company's strategy to strengthen its leadership as it expands its healthcare delivery model across the U.S.
Read more →-NUTX
Aug 20, 2025NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE
Nutex Health Inc. announced a financial reporting update, disclosing non-reliance on its previously issued financial statements due to changes in the classification of obligations. Despite this, the company reported remarkable revenue growth, with total revenue for Q2 2025 reaching $244 million, a 220.7% increase from the previous year. The company also achieved its highest cash collection in a quarter, totaling $175 million.
Read more →-NUTX
Aug 14, 2025▼ -16.4%on this newsshared move
NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION
Nutex Health Inc. reported a significant increase in revenue and gross profit for the second quarter of 2025, with total revenue rising to $244 million. However, the company announced a delay in filing its Form 10-Q due to non-cash accounting adjustments. Additionally, Nutex Health has initiated a stock repurchase program of up to $25 million to enhance shareholder value.
Read more →-NUTX
Aug 8, 2025Nutex Health Schedules 2025 Second Quarter Financial Results Release and Conference Call
Nutex Health Inc. will release its second quarter financial results for 2025 on August 14, followed by a conference call on August 15. The company operates a network of micro hospitals and physician groups across the U.S. and aims to provide innovative healthcare solutions. Investors are encouraged to participate in the call to gain insights into the company's performance.
Read more →-NUTX
Jul 29, 2025▼ -7.6%on this news
NUTEX HEALTH TO RING NASDAQ BELL AND MEET WITH INVESTORS IN NYC ON AUGUST 26
Nutex Health Inc. will ring the closing Nasdaq bell on August 26, 2025, in New York City. The event will be accompanied by an investor meet and greet earlier that day. Nutex Health, which operates 24 micro hospitals across 11 states, aims to strengthen its investor relations through this engagement.
Read more →-NUTX
Jul 24, 2025Nutex Health Responds to Short Seller Report
Nutex Health Inc. has responded to allegations made in a short seller report questioning its collection process. The company asserts that the report is misleading and contains misrepresentations about its business practices. Nutex Health plans to address these issues further in its upcoming earnings release and Form 10-Q, expected by August 14, 2025.
Read more →-NUTX
Jul 8, 2025▲ +9.6%on this news
NUTEX HEALTH HOSPITALS’ 2025 Q2 AWARDS
Nutex Health Inc. announced several awards received by its hospitals in Q2 2025, highlighting their commitment to patient care. The accolades, voted on by local communities, underscore the organization's focus on delivering superior healthcare. Notable awards include 'Best Emergency Care' and 'Top Doc' recognitions for specific physicians, affirming Nutex's reputation in the healthcare sector.
Read more →-NUTX
Jun 27, 2025NUTEX HEALTH ANNOUNCES THAT IT HAS FILED A SUPPLEMENT TO ITS PROXY STATEMENT
Nutex Health Inc. has filed a supplement to its proxy statement ahead of its Annual Meeting scheduled for July 14, 2025. Shareholders are encouraged to review the newly filed supplement, which follows a previous proxy statement filed on June 2, 2025. The company provides multiple options for stockholders to access the meeting materials.
Read more →-NUTX
Jun 24, 2025NUTEX HEALTH INC. ADDED TO RUSSELL 3000® INDEX AND RUSSELL MICROCAP® INDEX
Nutex Health Inc. has announced its addition to the Russell 3000 and Russell Microcap Indexes, effective June 30, 2025. This inclusion is part of the annual reconstitution of the Russell indexes, which ranks the largest U.S. stocks by market capitalization. The company views this as a significant validation of its business model and anticipates increased visibility among institutional investors.
Read more →-NUTX
Jun 3, 2025▼ -11.8%on this news· ran to -27% by day 3
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING
Nutex Health Inc. has announced the availability of its proxy materials for the 2025 annual meeting, scheduled for July 14, 2025. The meeting will be held virtually, allowing stockholders to participate online. The company is utilizing a 'notice only' option for proxy material delivery, ensuring stockholders are informed about accessing and voting on their shares.
Read more →-NUTX
May 22, 2025NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR
Nutex Health Inc. has appointed Grant Thornton LLP as its new independent auditor, effective May 15, 2025, replacing CBIZ CPAs. This decision was made after careful evaluation and was approved by the Audit Committee and the Board of Directors. The change is not due to any disagreements with CBIZ, and the company aims for a smooth transition.
Read more →-NUTX
May 13, 2025▲ +26.1%on this news· ran to +40% by day 3
NUTEX HEALTH REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
Nutex Health Inc. reported a remarkable financial performance for Q1 2025, with total revenue soaring to $211.8 million, a 213.8% increase from the previous year. The company achieved a net income of $14.6 million, reversing a loss from Q1 2024. Significant growth in EBITDA and cash from operating activities highlights the company's operational improvements and financial strength.
Read more →-NUTX
May 13, 2025NUTEX HEALTH reports FIRST quarter 2025 financial results Total revenue of $211.8 million Versus $67.5 Million IN q1 2024, an increase of 213.8% NET INCOME ATTRIBUTABLE TO nUTEX hEALTH iNC. OF $14.6 MILLION VERSUS Net LO
Nutex Health Inc. has reported impressive first-quarter financial results for 2025, showcasing a revenue increase of 213.8% to $211.8 million compared to the same period last year. The company also achieved a net income of $14.6 million, indicating a significant turnaround from a loss in the previous year. Key performance indicators highlight strong operational efficiency, with gross profit margins reaching a record high. Nutex Health attributes this success to improved operational strategies and a focus on patient care, positioning itself favorably for continued growth.
Read more →-NUTX
May 7, 2025▼ -11.6%on this news
Nutex Health Schedules 2025 First Quarter Financial Results Release and Conference Call
Nutex Health Inc. will release its financial results for Q1 2025 on May 13, 2025, followed by a conference call on May 14 at 10:30 a.m. ET. The company operates 24 micro hospitals across 11 states and aims to provide transparent communication to its stakeholders. Risks related to management dependence and regulatory changes are acknowledged.
Read more →-NUTX
Mar 31, 2025▲ +51.8%on this news
NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
Nutex Health Inc. reported substantial financial growth for the fourth quarter and full year 2024, with total revenue reaching $479.9 million, a 93.8% increase from 2023. The company achieved a net income of $52.2 million, reversing a loss from the previous year. Notably, adjusted EBITDA surged by over 1,000%, reflecting operational improvements and effective cost management. The arbitration process contributed significantly to revenue growth, indicating a positive trend for the company's financial health.
Read more →-NUTX
Mar 31, 2025▼ -9%on this news· ran to +39% by day 3shared move
NUTEX HEALTH reports FOURTH quarter and FULL year 2024 financial results Full year 2024 highlights: Total revenue of $479.9 million Versus $247.6 Million IN 2023, an increase of 93.8% NET INCOME OF $52.2 MILLION VERSUS N
Nutex Health Inc. has reported strong financial results for the fourth quarter and full year 2024, showcasing a 93.8% increase in total revenue compared to 2023. The company achieved a net income of $52.2 million, significantly improving upon the previous year’s losses. Operational improvements, including a 16.9% increase in hospital visits, were highlighted, driven in part by a successful arbitration initiative. As Nutex Health prepares for 2025, it aims to maintain its momentum and optimize operational efficiency.
Read more →-NUTX
Mar 27, 2025▼ -7.1%on this news· ran to +35% by day 3shared move
NUTEX HEALTH RESCHEDULES EARNINGS RELEASE AND CONFERENCE CALL
Nutex Health Inc. has rescheduled its earnings release and conference call for the fourth quarter and full year ended December 31, 2024. The financial results will now be issued after market close on March 31, 2025, with the conference call scheduled for April 1, 2025. This change allows the company to finalize its year-end reporting.
Read more →-NUTX
Mar 20, 2025Nutex Health to Present at the EDPMA Solutions Summit 2025
Nutex Health Inc. announced that its CEO, Dr. Tom Vo, will present at the EDPMA Solutions Summit 2025. The presentation, titled 'The Evolution of Micro Hospitals and How it Impacts Future Healthcare,' is scheduled for April 1, 2025. The summit will address critical topics in emergency medicine and provide networking opportunities for industry leaders.
Read more →-NUTX
Mar 17, 2025NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
Nutex Health Inc. has announced the release of its financial results for the fourth quarter and full year ending December 31, 2024. The results will be disclosed after market close on March 27, 2025, followed by a conference call on March 28, 2025, at 10:30 am ET. This event will allow stakeholders to discuss the company's performance.
Read more →-NUTX
Feb 5, 2025▲ +12.8%on this news
Nutex Health Issues No Surprises Act (NSA) Arbitration Update HOUSTON
Nutex Health Inc. provided an update on its participation in the arbitration process outlined in the No Surprises Act. The company reports a high success rate of over 80% in arbitration, enabling substantial recovery of previously underpaid claims. However, Nutex acknowledges the inherent costs of arbitration and uncertainties about future successes and regulatory changes that could impact its operations. The firm remains committed to optimizing its healthcare delivery model, despite the risks involved.
Read more →-NUTX
Jan 21, 2025Nutex Health Hospitals Earn Multiple Community Honors and Awards in Q4
Nutex Health Inc. announced that its hospitals earned several community honors in Q4 2024, showcasing their commitment to high-quality healthcare. Awards included 'Best Place to Work' and 'Best Hospital Emergency Room', reflecting patient satisfaction. The recognitions were voted on by the communities, emphasizing Nutex's focus on superior service and care.
Read more →-NUTX
Jan 13, 2025NUTEX HEALTH OPENS STARKEY RANCH ER & HOSPITAL, ITS FIRST HOSPITAL IN FLORIDA
Nutex Health has opened its first hospital in Florida, Starkey Ranch ER & Hospital, on December 30, 2024. This facility is part of Nutex's expansion strategy, featuring state-of-the-art medical services and a focus on patient-centered care. The hospital aims to provide high-quality emergency and inpatient care to the local community.
Read more →-NUTX
Jan 6, 2025NUTEX HEALTH TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Nutex Health Inc. announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, scheduled for January 13-16, 2025. The company will present on January 16, 2025, and management will be available for one-on-one meetings with investors. Nutex Health operates 24 micro-hospitals across 11 states, focusing on integrated healthcare delivery.
Read more →-NUTX
Nov 18, 2024NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN
Nutex Health has opened a new Milwaukee ER & Hospital, marking its third hospital opening in 2024. This facility provides 24/7 emergency care with state-of-the-art medical services, including imaging and laboratory services. The opening aims to serve the south Milwaukee area, which has been historically underserved in terms of healthcare access.
Read more →-NUTX
Nov 7, 2024▲ +9.2%on this news
NUTEX HEALTH REPORTS THIRD QUARTER AND YEAR TO DATE SEPTEMBER 30, 2024 FINANCIAL RESULTS
Nutex Health Inc. reported strong financial results for the third quarter and nine months ended September 30, 2024, with total revenue reaching $222.3 million, a 25% increase from the previous year. Operating income improved significantly to $16.4 million, while adjusted EBITDA surged by 290%. However, the company also reported a net loss of $9.5 million, reflecting ongoing challenges despite overall growth.
Read more →-NUTX
Nov 7, 2024▲ +6.3%on this news· ran to +38% by day 3shared move
NUTEX HEALTH reports third quarter and year to date
Nutex Health Inc. reported strong third-quarter financial results for 2024, showcasing a 25% revenue growth and a significant increase in gross profit. The company's adjusted EBITDA reached $13.5 million, highlighting enhanced profitability during the period. Despite these positive developments, Nutex reported a net loss of $8.79 million and faces an accumulating deficit. The management remains optimistic about sustaining growth and improving cash flow as they continue expanding their hospital and health divisions.
Read more →-NUTX
Nov 5, 2024▲ +8.5%on this news· ran to +37% by day 3shared move
NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
Nutex Health Inc. has announced the release of its financial results for Q3 2024, scheduled for November 7, 2024. A conference call will follow on November 8, 2024, at 10:30 am ET to discuss these results. The company operates a network of micro hospitals and physician groups across multiple states, focusing on integrated healthcare delivery.
Read more →-NUTX
Sep 30, 2024▲ +11.3%on this news
NUTEX HEALTH HOSPITALS WIN MULTIPLE AWARDS IN THE 3rd QUARTER OF 2024
Nutex Health Inc. announced that its hospitals received several community awards in Q3 2024, highlighting their commitment to patient care. The awards, voted on by local communities, reflect high patient satisfaction. Additionally, Nutex was recognized as one of the fastest-growing companies, and its leadership participated in key industry events.
Read more →-NUTX
Aug 26, 2024▲ +11.8%on this news
NUTEX HEALTH OPENS POST FALLS ER & HOSPITAL, ITS FIRST HOSPITAL IN IDAHO
Nutex Health has opened its first hospital in Idaho, the Post Falls ER & Hospital, which aims to provide 24/7 concierge-level care. The facility features advanced medical technology, including an imaging suite and in-house laboratory services. This opening marks Nutex's second hospital launch in 2024, enhancing healthcare access for residents in the region.
Read more →-NUTX
Aug 8, 2024▲ +27.8%on this news· ran to +64% by day 3
NUTEX HEALTH REPORTS SECOND QUARTER AND SIX MONTHS ENDED JUNE 30, 2024 FINANCIAL RESULTS
Nutex Health Inc. reported strong financial results for the second quarter and first half of 2024, with total revenue reaching $143.5 million, a 25% increase from the previous year. The company's hospital division saw a significant rise in operating income, up 140%, while adjusted EBITDA surged by 200%. Despite these gains, the company still reported a net loss of $0.4 million for the quarter.
Read more →-NUTX
Aug 8, 2024NUTEX HEALTH reports SECOND quarter and Six months ended
Nutex Health Inc. reported strong financial performance for the second quarter and first half of 2024, highlighting a 29% increase in revenue and significant growth in operating income. The company's CFO noted a continued focus on top-line growth and improving profitability. However, the report also indicated a net loss attributable to Nutex Health, alongside an increase in accumulated deficits and impairments. The company remains optimistic about its strategic initiatives aimed at sustainable growth and enhancing shareholder value.
Read more →-NUTX
Aug 6, 2024NUTEX HEALTH SCHEDULES 2024 SECOND QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
Nutex Health Inc. has scheduled the release of its second quarter financial results for August 8, 2024, followed by a conference call on August 9, 2024. The company operates 21 micro hospitals across 9 states and focuses on integrated healthcare delivery. Stakeholders are encouraged to participate in the call or access the recording later.
Read more →-NUTX
Jul 29, 2024▲ +7.2%on this news
NUTEX HEALTH REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE
Nutex Health Inc. has announced that it has regained compliance with Nasdaq's minimum bid price requirement. This follows a period where the company's stock price exceeded $1.00 per share after a reverse stock split. The Nasdaq has confirmed that the prior bid price deficiency matter is now resolved, allowing Nutex to maintain its listing on the Nasdaq Capital Market.
Read more →-NUTX
Jul 15, 2024▲ +8%on this news· ran to +32% by day 1
Nutex Health Hospitals Prove Patient Satisfaction with Nine Awards and Honors Earned in Q2
Nutex Health Inc. announced that its hospitals earned nine awards in Q2 2024, highlighting their commitment to patient care and community service. The accolades, voted on by local communities, recognize the hospitals' superior healthcare delivery. Key awards include 'Best Emergency Care' and 'Business of the Year,' showcasing the organization's focus on excellence.
Read more →-NUTX
Jun 27, 2024NUTEX HEALTH ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT
Nutex Health Inc. announced a 1-for-10 reverse stock split effective July 3, 2024, to comply with Nasdaq's minimum bid price requirement. This decision follows shareholder approval on June 17, 2024, and aims to consolidate shares from approximately 49 million to 4.9 million. The company continues its operations in integrated healthcare delivery with a focus on micro-hospitals and physician networks.
Read more →-NUTX
Jun 19, 2024▲ +5.9%on this news
NUTEX HEALTH ANNOUNCES THAT IT HAS OBTAINED APPROVAL FROM ITS SHAREHOLDERS TO EFFECT A REVERSE STOCK SPLIT
Nutex Health Inc. has received shareholder approval for a reverse stock split ranging from 1-for-2 to 1-for-16. This move aims to help the company regain compliance with NASDAQ's minimum bid requirement by July 22, 2024. However, the company acknowledges that the reverse stock split may not guarantee compliance or predict its impact on stock prices.
Read more →-NUTX
May 24, 2024▼ -5.9%on this news
NUTEX HEALTH ANNOUNCES NASDAQ DELISTING NOTIFICATION AND STAY PENDING ONGOING APPEAL. NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMMON STOCK.
Nutex Health Inc. has received a delisting notification from Nasdaq due to non-compliance with the minimum bid price requirement. The company has appealed this decision, and the delisting action is currently stayed pending a hearing scheduled for July 9, 2024. A reverse stock split has been approved to help regain compliance, but the outcome remains uncertain.
Read more →-NUTX
May 9, 2024NUTEX HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Nutex Health Inc. reported a strong financial performance for Q1 2024, with total revenue reaching $67.5 million, a 20% increase from the previous year. The hospital division saw significant growth, with visits up 21.1% and operating income up 119%. Despite a net loss of $0.4 million, the company generated positive cash flow and improved its adjusted EBITDA by 92%. The leadership expressed optimism about ongoing growth and financial stability.
Read more →-NUTX
May 9, 2024NUTEX HEALTH reports FIRST quarter 2024 financial results Total revenue of $67.5 million for fIRST qUARTER 2024 vs $56.3 Million in 2023, an increase of 20% HOSPITAL DIVISION VISITS OF 40,068 FOR THE FIRST QUARTER 2024 V
Nutex Health Inc. (NUTX) reported a 20% increase in total revenue for the first quarter of 2024, amounting to $67.5 million, up from $56.3 million in the same period in 2023. The company's hospital division experienced a 119% increase in operating income, reaching $10.5 million. Despite these positive financial metrics, Nutex reported a net loss of $364,075. The company maintains a solid cash position, indicating ongoing growth potential and financial stability.
Read more →-NUTX
May 7, 2024▼ -9.5%on this newsshared move
NUTEX HEALTH SCHEDULES 2024 FIRST QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
Nutex Health Inc. has announced the release of its financial results for Q1 2024, scheduled for May 8, 2024. A conference call to discuss these results will take place on May 10, 2024. The company operates 21 micro hospitals across 9 states and focuses on integrated healthcare delivery.
Read more →-NUTX
May 6, 2024▼ -9.5%on this newsshared move
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2024 ANNUAL MEETING
Nutex Health Inc. has announced the availability of its proxy materials for the 2024 Annual Meeting, scheduled for June 17, 2024. The meeting will be held virtually, allowing stockholders to participate and vote online. The company is using a 'notice only' option for proxy material delivery, ensuring that stockholders can easily access necessary information.
Read more →-NUTX
Apr 29, 2024▼ -5.4%on this news
NUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCE
Nutex Health Inc. is set to host its second annual leadership conference from April 30 to May 2 in Houston, Texas. The event will gather leaders to discuss strategic planning, best practices, and business development initiatives aimed at reducing costs and improving financial performance. This invitation-only conference is part of Nutex's strategic plan for 2024.
Read more →-NUTX
Apr 22, 2024NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS
Nutex Health Inc. has announced the appointment of Scott J. Saunders and Dr. Kelvin Spears to its Board of Directors, replacing the late John Waters and Dr. Daniel Stites. Both new directors bring extensive experience in healthcare and management. The company aims for long-term profitability despite previous challenges.
Read more →-NUTX
Apr 16, 2024▲ +29.4%on this news
Nutex Health Hospitals Gain Community Recognition and Take Home Seven Patient Satisfaction Awards in Q1
Nutex Health Inc. announced that its hospitals won seven awards and four recognitions in Q1 2024, highlighting their commitment to patient care. The awards were based on community votes, showcasing the hospitals' excellence in healthcare delivery. Notable recognitions included awards for specific facilities and leadership accolades for key personnel.
Read more →-NUTX
Apr 8, 2024NUTEX HEALTH OPENS FIRST HOSPITAL OF 2024 IN BELLEVUE, WISCONSIN
Nutex Health has opened its first hospital of 2024, the Green Bay ER & Hospital, in Bellevue, Wisconsin. This facility features advanced medical services, including emergency care and inpatient beds, and aims to provide high-quality healthcare to the local community. The opening follows a successful open house event that attracted significant local interest. Nutex plans to open another hospital in Milwaukee later this year.
Read more →-NUTX
Apr 5, 2024▼ -12.3%on this news· ran to -27% by day 3shared move
NUTEX HEALTH ANNOUNCES 1-FOR-15 REVERSE STOCK SPLIT
Nutex Health Inc. has announced a 1-for-15 reverse stock split effective April 10, 2024. This action is intended to help the company meet the minimum bid price requirements for continued listing on the Nasdaq Capital Market. The split will reduce the number of outstanding shares from approximately 745 million to about 50 million, while the number of authorized shares remains unchanged.
Read more →-NUTX
Mar 28, 2024NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Nutex Health Inc. reported its financial results for Q4 and the full year 2023, showing a 13% increase in total revenue to $247.6 million. The hospital division's operating income rose significantly by 142% to $36.3 million. However, the company faced a net loss of $45.8 million, influenced by substantial non-cash impairment charges. Management is implementing strategies to enhance cash flow and optimize resources moving forward.
Read more →-NUTX
Mar 28, 2024▼ -6%on this newsshared move
NUTEX HEALTH reports fourth quarter and Full YEAR 2023 financial results Total revenue of $247.6 million for the year ended 2023 vs $219.3 Million in 2022, an increase of 13% hospital division operating income of $36.3 m
Nutex Health Inc. reported its financial results for the fourth quarter and full year of 2023, showcasing a year-over-year revenue increase of 13%, amounting to $247.6 million. The hospital division experienced a remarkable 142% rise in operating income, totaling $36.3 million. However, the company also revealed a net loss of $43.4 million for the year and an increased accumulated deficit. The management has initiated a strategic plan aimed at expense reduction and resource optimization to improve financial performance moving forward.
Read more →-NUTX
Mar 15, 2024NUTEX HEALTH ANNOUNCES PRELIMINARY 2023 HEADLINE FINANCIALS AND PROVIDES UPDATE ON THE TIMING OF ITS 10-K FILING
Nutex Health Inc. announced preliminary financial results for FY 2023, reporting total revenue of $247.6 million, an increase from the previous year. However, the company also reported a net loss of $44.2 million, which includes significant impairment charges. Nutex is expected to file its 10-K next week, within the SEC's extension deadline.
Read more →-NUTX
Feb 5, 2024NUTEX HEALTH ANNOUNCES OVER 100% INCREASE IN MEDICARE ADVANTAGE ENROLLMENT
Nutex Health Inc. has reported a significant increase in Medicare Advantage enrollment, more than doubling its membership during the 2023 annual enrollment period. The company enrolled over 2400 new patients, bringing its total to over 4500 members across its network. This growth is attributed to targeted investments in population health management, and Nutex plans to expand into new markets in 2024.
Read more →-NUTX
Jan 31, 2024/C O R R E C T I O N — Nutex Health, Inc./
Nutex Health, Inc. has announced a streamlined strategic plan aimed at enhancing shareholder value and financial stability. The company has fully paid off a $2.7 million balance under its Pre-Paid Advance Agreement and will close two underperforming hospitals, saving approximately $5 million annually. Additionally, Nutex plans to open five new micro hospitals in 2024, despite facing macroeconomic challenges.
Read more →-NUTX
Jan 30, 2024NUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLAN
Nutex Health Inc. has announced the full payoff of its $2.7 million debt to Yorkville Advisors, aiming to improve its financial standing. The company is also implementing a streamlined strategic plan that includes closing two underperforming hospitals to save approximately $5 million annually. Despite economic challenges, Nutex plans to open five new micro hospitals in 2024, focusing on increasing revenue and profitability.
Read more →-NUTX
Jan 24, 2024RISK FACTORS As of the date of this Current Report, the Company updates and supplements the risk factors disclosed in its Annual Report on Form 10-K for the fiscal year ended
NUTX has updated its risk factors, highlighting critical financial challenges as it navigates operational losses and funding. The company may face difficulties in raising sufficient capital for its expansion plans, potentially necessitating equity offerings that could dilute current stockholders. Additionally, the closure of underperforming hospitals could lead to short-term revenue declines, and reimbursement changes for emergency services raise further uncertainties. This could have a significant adverse effect on the company's financial health and operational outlook.
Read more →-NUTX
Jan 23, 2024▼ -26.2%on this newsshared move
Nutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and Warrants
Nutex Health Inc. has announced a registered direct offering of common stock and warrants, aiming to raise $10 million. The offering involves the sale of 66,666,666 shares at $0.15 each, with the transaction expected to close by January 25, 2024. Maxim Group LLC is the placement agent for this offering, which follows an effective shelf registration statement filed with the SEC.
Read more →-NUTX
Jan 11, 2024▼ -10.4%on this news
S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L C O N F I D E N T I A L 2 General The information contained in this Investor Presentation (“P
Nutex Health is focusing on long-term growth through the expansion of its micro-hospital facilities, with 22 locations opened in 2023 and plans for additional facilities in 2024 and 2025. The company aims to provide high-quality and cost-effective healthcare while leveraging its portfolio of coordinated assets. Recent financial reports indicate positive operating cash flow, and strategic plans include enhancing revenue cycle management due to regulatory challenges. Overall, Nutex Health is well-positioned within an attractive healthcare market but faces challenges linked to its financing and regulatory landscape.
Read more →-NUTX
Dec 18, 2023▼ -5.1%on this news
NUTEX HEALTH TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Nutex Health Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10-11, 2024, in San Francisco. CEO Thomas Vo and President Warren Hosseinion will lead the presentation, which will be followed by one-on-one meetings with investors. The company operates a network of micro hospitals and physician networks across multiple states.
Read more →-NUTX
Nov 27, 2023▼ -8%on this news· ran to -20% by day 3
NUTEX HEALTH ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
Nutex Health Inc. has been granted a 180-day extension by Nasdaq to meet the minimum bid price requirement of $1.00 per share. The company aims to achieve this by May 20, 2024, and is considering options such as a reverse stock split if necessary. Shareholder approval for such a split is already in place.
Read more →-NUTX
Nov 9, 2023NUTEX HEALTH REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS
Nutex Health Inc. reported strong financial results for Q3 2023, with net revenue reaching $62.7 million, a substantial increase from the previous year. The company also reported a positive adjusted EBITDA of $1.3 million and plans to open five new micro-hospitals in 2024. However, it continues to face challenges with a net loss of $(5.5) million and a large accumulated deficit.
Read more →-NUTX
Nov 9, 2023NUTEX HEALTH reports THIRd quarter 2023 financial results NET revenue of $62.7 million NET CASH FROM OPERATING ACTIVITIES OF $2.0 MILLION Company expects to open FIVE NEW MICRO-HOPITALS IN 2024 HOUSTON, TX (PRNewswire)
Nutex Health Inc. announced its financial results for the third quarter of 2023, reporting a net revenue of $62.7 million, marking a significant increase compared to the previous year. The company highlighted positive trends in operational cash flow and plans to expand by opening five new micro-hospitals in 2024. However, it also reported a net loss of $5.54 million during the quarter, alongside a considerable accumulated deficit. The company aims to continue executing its growth strategy while managing existing liabilities.
Read more →-NUTX
Nov 6, 2023Two Nutex Health Hospitals Won Awards in October
Nutex Health Inc. announced that two of its hospitals won community awards in October. Fort Smith ER & Hospital received the 'Silver Best Hospital' award, while Texarkana Emergency Center & Hospital was named 'Best Hospital' in the Texarkana Gazette's Readers' Choice awards. These accolades highlight Nutex's focus on patient care and quality healthcare delivery.
Read more →-NUTX
Nov 1, 2023▲ +13.5%on this news· ran to +35% by day 1shared move
Nutex Health Chairman and CEO Tom Vo to Speak on Panel at Upcoming Danaher Summit on Diagnostics
Nutex Health Inc. announced that its Chairman and CEO, Dr. Thomas Vo, will participate as a panelist at the Danaher Summit on Diagnostics in Washington, D.C. on November 7, 2023. Dr. Vo will discuss diagnostic insights impacting healthcare systems alongside other notable healthcare leaders. This event underscores Nutex Health's commitment to innovative healthcare delivery.
Read more →-NUTX
Oct 4, 2023NUTEX HEALTH LAUNCHES INNOVATIVE PSYCHIATRIC SERVICES AT TEXAS HOSPITAL
Nutex Health Inc. has launched 24/7 behavioral health services at SE Texas ER & Hospital, allowing for immediate psychiatric evaluations and treatment in the emergency room. This initiative aims to address the critical need for mental health services and reduce ER boarding times for psychiatric patients. The program is designed to provide expedient and individualized care, enhancing the overall patient experience.
Read more →-NUTX
Sep 20, 2023NUTEX HEALTH ANNOUNCES PARTICIPATION IN THE 2023 CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE
Nutex Health Inc. announced its participation in the 2023 Cantor Fitzgerald Global Healthcare Conference, scheduled for September 26-28 in New York City. CEO Thomas Vo will present on September 28 and is available for one-on-one meetings with investors. The company operates 22 micro hospitals across eight states and focuses on integrated healthcare delivery.
Read more →-NUTX
Sep 7, 2023NUTEX HEALTH ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCES
Nutex Health Inc. announced its participation in two upcoming investor conferences, including the H.C. Wainwright 25th Annual Global Investment Conference on September 13, 2023, and the Northland Capital Markets Institutional Investor Conference on September 19, 2023. Management will engage in one-on-one meetings with investors at both events. The company emphasizes its innovative healthcare delivery model and technology.
Read more →-NUTX
Sep 5, 2023▲ +8.3%on this newsshared move
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JOSHUA DETILLIO AS ITS NEW CHIEF OPERATING OFFICER
Nutex Health Inc. has appointed Joshua DeTillio as its new Chief Operating Officer, effective October 2, 2023. DeTillio, with over 20 years of experience in the healthcare sector, previously served as CEO at Bravera Health and Palms West Hospital. His leadership is expected to enhance Nutex's operational efficiency and revenue growth in a competitive healthcare market.
Read more →-NUTX
Aug 22, 2023NUTEX HEALTH ANNOUNCES THE ACQUISITION OF POPULATION HEALTH ASSOCIATES AND MANAGED CARE INSURANCE CONSULTANTS
Nutex Health has acquired Population Health Associates and Managed Care Insurance Consultants, adding approximately 112 primary care physicians and 4400 managed care patients to its network. This acquisition aims to enhance Nutex's operations in Florida and leverage its cloud-based health management platform. The company plans to open 5-6 new micro-hospitals in Florida by 2025, further expanding its healthcare delivery model.
Read more →-NUTX
Aug 22, 2023NUTEX HEALTH ANNOUNCES THE ACQUISITION OF POPULATION HEALTH ASSOCIATES AND MANAGED CARE INSURANCE CONSULTANTS ACQUISITION EXPANDS COMPANY'S PRESENCE IN FLORIDA AND ADDS APPROXIMATELY 112 PRIMARY CARE PHYSICIANS AND 4400
Nutex Health Inc. has announced the acquisition of Population Health Associates and Managed Care Insurance Consultants, significantly expanding its operations in Florida. The deal will introduce approximately 112 primary care physicians and add about 4,400 managed care patients to its system. This acquisition aligns with Nutex's strategy of building integrated healthcare models and enhances its existing patient network. The company's plans for further expansion in Florida include the opening of 5-6 micro-hospitals by the end of 2025.
Read more →-NUTX
Aug 9, 2023NUTEX HEALTH REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
Nutex Health Inc. reported its financial results for Q2 2023, highlighting a net revenue of $58.9 million and an adjusted EBITDA of $4.0 million. Despite a net loss of $3.5 million, the company is optimistic about future growth, planning to open additional micro-hospitals and expand its independent practice associations. The company also noted improvements in its population health analytics platform.
Read more →-NUTX
Aug 9, 2023NUTEX HEALTH reports Second quarter 2023 financial results NET revenue of $58.9 million Company expects to open 1-2 more hospitals in 2023 and another 14 by end of 2025 HOUSTON, TX (PRNewswire) - AUGUST 9, 2023 - Nutex H
Nutex Health Inc. announced its financial results for the second quarter of 2023, reporting a net revenue of $58.9 million and an adjusted EBITDA increase to $4.0 million. The company plans to open 1-2 additional hospitals in 2023 and is strategically expanding with new physician networks. However, Nutex reported a net loss of $3.5 million for the quarter, indicating challenges despite increased operational capacity. Overall, the company maintains a positive outlook for growth in patient volumes and service lines for the remainder of the year.
Read more →-NUTX
Aug 7, 2023▼ -6.6%on this newsshared move
NUTEX HEALTH ANNOUNCES THE OPENING OF A NEW HOSPITAL IN TEXAS, BRINGING THE FIRST HOSPITAL AND MRI TO ROYSE CITY
Nutex Health Inc. has announced the opening of its new microhospital, Royse City Emergency Hospital, in Texas. This facility is notable for being the first hospital and MRI provider in Royse City, enhancing healthcare access for the local community. The hospital is Nutex's fourth new facility in 2023, with plans for more openings this year. The company aims to expand its presence in Texas, where it is headquartered.
Read more →-NUTX
Jul 31, 2023▲ +7.4%on this news
NUTEX HEALTH ANNOUNCES THAT ITS ADVANCED POPULATION HEALTH ANALYTICS PLATFORM HAS BEEN SELECTED BY VARMED MANAGEMENT TO ENHANCE PATIENT CARE
Nutex Health has partnered with Varmed Management to utilize its Clinigence Health analytics platform, enhancing patient care and population health management. This collaboration aims to improve healthcare outcomes while reducing costs through advanced analytics. The partnership reflects a commitment to delivering high-quality, accessible care to communities.
Read more →-NUTX
Jul 18, 2023NUTEX HEALTH HOSPITALS WIN SIX NEW OUTSTANDING AWARDS
Nutex Health Inc. announced that six of its hospitals have won notable community awards, reflecting high patient satisfaction and quality emergency care. The awards include recognitions such as 'Best Places to Work' and 'Best Emergency Room.' CEO Tom Vo emphasized the importance of patient care in achieving these accolades, showcasing the company's commitment to quality healthcare delivery.
Read more →-NUTX
May 15, 2023▲ +9%on this news
NUTEX HEALTH reports FIRST quarter 2023 financial results NET revenue of $56.3 million Net cash from operating activities of $1.1 million Company expects to open 4-5 more hospitals in 2023 and another 14 by end of 2025 H
Nutex Health Inc. reported its financial results for the first quarter of 2023, showing a net revenue of $56.3 million, although it also experienced a net loss of $5.1 million. The company is planning to expand its operations by opening 4-5 additional micro hospitals this year, which reflects its growth strategy amid challenging market conditions. Nutex's balance sheet remains strong, with $32.8 million in cash, providing financial support for its growth initiatives.
Read more →-NUTX
Apr 11, 2023NUTEX HEALTH announces that it has entered into a $100 million pre-paid advance agreement with yorkville advisors global l.p. HOUSTON, TX (PRNewswire) - APRIL 11, 2023 - Nutex Health Inc. ("Nutex Health" or the "Company"
Nutex Health Inc. has announced a significant $100 million pre-paid advance agreement with Yorkville Advisors Global L.P. The financing will be used to support the company's growth initiatives, including expanding its healthcare footprint and facilitating opportunistic acquisitions. The agreement allows Nutex Health to draw advances based on certain conditions and is seen as a positive endorsement of its integrated, value-based healthcare model. Nutex operates multiple healthcare facilities across several states, emphasizing technology-enabled delivery systems.
Read more →-NUTX
Apr 5, 2023▲ +5.9%on this newsshared move
NUTEX HEALTH announces change to its board of directors HOUSTON, TX (PRNewswire) - APRIL 5, 2023 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated health
Nutex Health Inc. announced changes to its Board of Directors, with Dr. Matthew Young departing after a one-year term. Dr. Danniel Stites has been elected to the Board, bringing over 10 years of experience in emergency medicine and management roles at various healthcare facilities. The company expressed appreciation for Dr. Young's service and highlighted the valuable expertise Dr. Stites will contribute as it aims to grow its business.
Read more →-NUTX
Mar 2, 2023NUTEX HEALTH Inc. reports fourth quarter and Full YEAR 2022 financial results Total revenue of $219.3 million for the year ended 2022 Net cash from operating activities of $50.6 million for the YEAR ended 2022 Company ex
NUTEX HEALTH Inc. reported its fourth quarter and full year 2022 financial results, highlighting a total revenue of $219.3 million. Despite a challenging year marked by a non-cash goodwill impairment and lower patient visits, the company is focusing on strategic initiatives to enhance future performance. With plans to expand its facilities and grow its independent practice association, Nutex aims to improve its financial health in the coming years.
Read more →-NUTX
Feb 28, 2023▲ +5.4%on this newsshared move
Nutex Health Inc. Investor Presentation.
Nutex Health Inc. Investor Presentation.
Read more →-NUTX
Dec 21, 2022NUTEX HEALTH to present at the 41 st Annual J.P. Morgan Healthcare conference HOUSTON, TX (PRNewswire) - DECEMBER 21, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology
NUTEX HEALTH to present at the 41st Annual J.P. Morgan Healthcare conference HOUSTON, TX (PRNewswire) - DECEMBER 21, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised
Read more →-NUTX
Nov 22, 2022NUTEX HEALTH reports THIRD quarter 2022 financial results and announces Common stock purchase agreement for a commitment to purchase up to $100 million worth of shares of its common stock with lincoln park capital Net ca
HEALTH reports THIRD quarter 2022 financial results and announces stock purchase agreement for a commitment to purchase up to $100 million worth of shares of its common stock with - Net cash from operating activities of $46.1 million for the nine months ended September 30, 2022
Read more →-NUTX
Oct 10, 2022NUTEX HEALTH PROVIDES CORPORATE UPDATE HOUSTON, TX (PRNewswire)
HEALTH PROVIDES CORPORATE UPDATE TX (PRNewswire) - October 10, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, healthcare management and operations company comprised of 21 micro hospitals in 8 states and primary care-centric, risk-be
Read more →-NUTX
Aug 22, 2022NUTEX HEALTH reports secONd quarter 2022 financial results EBITDA of $5.4 million for the second quarter of 2022 adjusted ebitda of $9.4 million for the second quarter of 2022 NET loss of $19.4 MILLION FOR THE SECOND QUA
HEALTH reports secONd quarter 2022 financial results TX (PRNewswire) - AUGUST 22, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospital
Read more →-NUTX
Jun 16, 2022to this filing for a detailed description of the revisions as of and for the year ended
HEALTH HOLDCO SUPPLEMENTAL INFORMATION Health Inc. ("Nutex Health" or the "Company"), is a physician-led, technology-enabled healthcare services company comprised of its wholly owned subsidiary Nutex Health Holdco, LLC , with the 21 hospital facilities in eight states (hospital
Read more →-NUTX
Jun 10, 2022Nutex health announces the appointment of jon bates as its new CHIEF FINANCIAL OFFICER HOUSTON, TX (PRNewswire)
health announces the appointment of jon bates as its new CHIEF FINANCIAL OFFICER TX (PRNewswire) - June 10, 2022 - Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital divisio
Read more →-NUTX
Apr 1, 2022CLINIGENCE HOLDINGS and nutex health announce completion of merger and listing on the nasdaq capital market FT. LAUDERDALE, FL and HOUSTON, TX (PRNewswire)
HOLDINGS and nutex health announce completion of merger and listing on the nasdaq capital market FL and HOUSTON, TX (PRNewswire) - April 1, 2022 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), a primary care-centric, technology-enabled, risk-bearing pop
Read more →-NUTX
Mar 17, 2022CLINIGENCE HOLDINGS ANNOUNCES RESULTS OF 2022 SPECIAL MEETING OF STOCKHOLDERS FT. LAUDERDALE, FL (PRNewswire) - MARCH 16, 2022 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC:CLNH), a leading technology-
HOLDINGS ANNOUNCES RESULTS OF 2022 SPECIAL MEETING OF STOCKHOLDERS LAUDERDALE, FL (PRNewswire) - MARCH 16, 2022 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC:CLNH), a leading technology-enabled, risk-bearing population health management company, today announc
Read more →-NUTX
Nov 23, 2021AGREEMENT AND PLAN OF MERGER BY AND AMONG NUTEX HEALTH HOLDCO LLC, CLINIGENCE HOLDINGS, INC., NUTEX ACQUISITION LLC, MICRO HOSPITAL HOLDING LLC (SOLELY FOR THE PURPOSES OF CERTAIN SECTIONS OF ARTICLE IV, SECTION 12.15
HOSPITAL HOLDING LLC (SOLELY FOR THE PURPOSES OF CERTAIN SECTIONS OF ARTICLE IV, SECTION 12.15 AND THE SECTIONS RELATED THERETO), HEALTH LLC (SOLELY FOR THE PURPOSES OF SECTION 4.18 AND THE SECTIONS RELATED THERETO) T. VO, IN HIS CAPACITY AS THE NUTEX REPRESENTATIVE AS OF NOVE
Read more →-NUTX
Oct 21, 2021CLINIGENCE HOLDINGS announces the acquisition of procare health FT. LAUDERDALE, FL (PRNewswire)
HOLDINGS announces the acquisition of procare health LAUDERDALE, FL (PRNewswire) - October 21, 2021 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), one of the nation's leading technology-enabled, risk-bearing population health management companies, tod
Read more →-NUTX
May 21, 2021CLINIGENCE HOLDINGS announces the SIGNING OF A BINDING LETTER OF INTENT TO ACQUIRE PROCARE HEALTH FT. LAUDERDALE, FL (PRNewswire)
HOLDINGS announces the SIGNING OF A BINDING LETTER OF INTENT ACQUIRE PROCARE HEALTH LAUDERDALE, FL (PRNewswire) - May 21, 2021 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), one of the nation's leading technology-enabled, risk-bearing population healt
Read more →-NUTX
Mar 2, 2021CLINIGENCE HOLDINGS announces the successful acquisitions of accountable healthcare america, inc. and AHP Management, inc. to form one of the nation's leading technology-enabled population health management companies ATL
HOLDINGS announces the successful acquisitions of healthcare america, inc. and AHP Management, inc. to form one of the leading technology-enabled population health management companies GA (PRNewswire) - March 2, 2021 - Clinigence Holdings, Inc. ("Clinigence" or the "Company")
Read more →-NUTX
Jul 15, 2020clinigence holdings provides strategic update ATLANTA, GA (BUSINESSWIRE)
holdings provides strategic update GA (BUSINESSWIRE) - July 15, 2020 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), a pioneer in clinical data integration, clinical quality reporting and population health analytics, today is providing an update to its
Read more →-NUTX
Jun 27, 2020From: Mark Fawcett Sent: Saturday
June 27, 2020 6:16 PM am resigning from the Board effective immediately. activities helping to raise capital for my Board role with Apollo, and my full time job leave me little time for anything else. I think the remaining Board has the skill and experience to bring the compan
Read more →-NUTX
Jun 3, 2020clinigence holdings and accountable healthcare america provide new update to shareholders ATLANTA, GA and FT. LAUDERDALE, FL (BUSINESSWIRE)
holdings and accountable healthcare america provide new update GA and FT. LAUDERDALE, FL (BUSINESSWIRE) - June 3, 2020 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: CLNH), a pioneer in clinical data integration, clinical quality reporting and population heal
Read more →-NUTX
May 16, 2020Lawrence Schimmel, M.D., FACS
Schimmel, M.D., FACS Hosseinion, Chairman Ivan Allen Jr. Blvd., Suite 875 follow-up to our recent conversation; due to outside obligations, I will no longer be able to serve as a member of the Board of Directors of Clinigence Holdings, Inc. effective today May 16, 2020. Schi
Read more →-NUTX
Nov 12, 2019CLINIGENCE HOLDINGS and accountable healthcare america sign letter of intent to merge ATLANTA, GA and FT. LAUDERDALE, FL (BUSINESSWIRE)
HOLDINGS and accountable healthcare america sign letter of intent to merge GA and FT. LAUDERDALE, FL (BUSINESSWIRE) - November 12, 2019 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") (OTC: IGMBD), a pioneer in clinical data integration, clinical quality reporting a
Read more →-NUTX
Oct 31, 2019CLINIGENCE HOLDINGS, INC. GOES PUBLIC VIA A REVERSE MERGER WITH IGAMBIT, INC. ATLANTA, GA (BUSINESSWIRE)
HOLDINGS, INC. GOES PUBLIC VIA A REVERSE MERGER WITH IGAMBIT, INC. GA (BUSINESSWIRE) - October 31, 2019 - Clinigence Holdings, Inc. ("Clinigence" or the "Company") announced today that it has become a publicly-traded company via a reverse merger with iGambit, Inc. ("iGambit")
Read more →-NUTX
Aug 9, 2019iGambit and clinigence holdings announce transformational merger SMITHTOWN, NY AND ATLANTA, GA (GLOBE NEWSWIRE)
and clinigence holdings announce transformational merger NY AND ATLANTA, GA (GLOBE NEWSWIRE) - August 9, 2019 - iGambit, Inc. ("iGambit" or "the Company") (OTC: IGMB), a fully reporting publicly-held company that wholly owns HealthDatix, a healthcare technology company with a
Read more →-NUTX
Jun 27, 2019iGambit Inc. and Clinigence Holdings Inc. sign Letter of Intent for Merger SMITHTOWN, N.Y.
Inc. and Clinigence Holdings Inc. sign Letter of Intent for Merger N.Y., June 27, 2019 (Globe Newswire) iGambit, Inc. (OTCMKTS: IGMB) is pleased to announce that it has entered into a Letter of Intent ("LOI") with Clinigence Holdings Inc. ("Clinigence") merger with Clinigence
Read more →-NUTX
Sep 7, 2018John Salerno, Chairman AMENDMENT #1 LETTER OF INTENT TO PURCHASE Personal and Confidential To: Winpoint Health LLC Date
#1 LETTER OF INTENT TO PURCHASE Amendment to the Letter of Intent refer to the Letter of Intent ("LOI") between the iGambit Inc. ("IGI") and Winpoint Health Inc. ( Winpoint" or "Company") and together referred to as ("Parties") dated June 14, 2018 ("Letter of Intent") with re
Read more →-NUTX
Jun 19, 2018Winpoint Health LLC and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire Winpoint Health
Health LLC and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire Winpoint Health LLC N.Y., June 19, 2018 (Globe Newswire) iGambit, Inc. (OTCBB: IGMB) is pleased to announce that it has entered into a Letter of Intent ("LOI") with Winpoint Health LLC. acquisition o
Read more →-NUTX
Jul 26, 2017During the past several months some significant events have occurred at iGambit.
To our Shareholders, Recent Company Events During the past several months some significant events have occurred at iGambit. On February 14, 2017 we acquired HubCentrix, Inc. (HubCentrix) and on April 6, 2017 we acquired the assets of the CyberCare Health Network Division from E
Read more →-NUTX
Jul 5, 2017Converted by EDGARwiz IGAMBIT Announces Sale of ARCMAIL TECHNOLOGIES and $6,000,000 liabilities reduction from Balance Sheet Press Release : iGambit Inc. - Friday
ARCMAIL TECHNOLOGIES and $6,000,000 liabilities reduction from Balance Sheet Press Release: iGambit Inc. - Friday, July 5, 2017 2PM EST SMITHTOWN, NY, July 5, 2017 Marketwire/ -- iGambit Inc. (OTCQB: IGMB), announced that on June 29, 2017 it completed the sale of its wholly o
Read more →-NUTX
May 8, 2017Converted by EDGARwiz IGAMBIT Announces Dr. Benedict S Maniscalco joins its Advisory Board. Press Release : iGambit Inc. Monday
IGAMBIT Announces Dr. Benedict S Maniscalco joins its Advisory Board. Press Release: iGambit Inc. Monday May 8, 2017 3:30PM EST SMITHTOWN, NY, May 8, 2017 Marketwire/ -- iGambit Inc. (OTCQB: IGMB), announced that Dr. Benedict S Maniscalco has joined its Senior Advisory Board.
Read more →-NUTX
Apr 6, 2017Converted by EDGARwiz IGAMBIT Announces Acquisition of CyberCare Health Network, Inc. Press Release: iGambit Inc. Thursday
IGAMBIT Announces Acquisition of CyberCare Health Network, Inc. Press Release: iGambit Inc. Thursday, April 6, 2017 2:30PM SMITHTOWN, NY, April 7, 2017 Marketwired -- iGambit Inc. (OTCQB: IGMB), announced that on April 6, 2017 it acquired the CyberCare Health Network Divisio
Read more →-NUTX
Feb 15, 2017Converted by EDGARwiz IGAMBIT Announces Acquisition of HUBCENTRIX INC. A Leading Provider of Healthcare Technology Press Release : iGambit Inc. Wednesday
IGAMBIT Announces Acquisition of A Leading Provider of Healthcare Technology Press Release: iGambit Inc. Wednesday, February 15, 2017 2PM EST SMITHTOWN, NY, February 15, 2017 Marketwire/ -- iGambit Inc. (OTCQB: IGMB), announced that on February 14, 2017 it acquired HubCentri
Read more →-NUTX
Aug 26, 2016Converted by EDGARwiz HubCentrix Inc. and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire the assets of HubCentrix Inc. Smithtown, NY (Marketwired
HubCentrix Inc. and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire the assets of HubCentrix Inc. Smithtown, NY (Marketwired - August 26, 2016), HubCentrix and iGambit Inc.(OTCQB:IGMB) sign LOI . Under the terms of the LOI, iGambit Inc. will acquire substantial
Read more →-NUTX
Aug 15, 2016Converted by EDGARwiz EncounterCare and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire certain assets of CyberCare Health Network Inc. Smithtown, NY. (Marketwired - August 15 th , 2016 ), iG
EncounterCare and iGambit Inc. sign Letter of Intent for iGambit Inc. to acquire certain assets of CyberCare Smithtown, NY. (Marketwired - August 15th, 2016), iGambit Inc. (OTCQB:IGMB) iGambit Inc. announced it has entered into a LOI with EncounterCare Solutions Inc. (ECSL).
Read more →-NUTX
Nov 11, 2015Converted by EDGARwiz IGAMBIT Announces Sale of Gotham Subsidiary Press Release : iGambit Inc. - Tuesday
IGAMBIT Announces Sale of Gotham Press Release: iGambit Inc. - Tuesday November 11, 2015 2 PM EST SMITHTOWN, NY., November 11, 2015 Marketwire/ -- iGambit Inc. (OTCQB: IGMB), a diversified holding company, announced that on November 5, 2015, through its wholly owned subsidiar
Read more →-NUTX
May 13, 2015Converted by EDGARwiz IGAMBIT Files, Form 8-K Announces Execution of Letter of Intent to Acquire United Fertility Centers of America Press Release : iGambit Inc. Wed
IGAMBIT Files, Form 8-K Announces Execution of Letter of Intent to Acquire United Fertility Centers of America Press Release: iGambit Inc. Wed, May 13, 2015 2 PM EST SMITHTOWN, NY., May 13, 2015 /Marketwire/ -- iGambit Inc. (OTCQB: IGMB), a diversified holding company, annou
Read more →-NUTX
Apr 26, 2013LETTER OF RESIGNATION JOHN WATERS Converted by EDGARwiz
LETTER OF RESIGNATION JOHN WATERS Converted by EDGARwiz
Read more →-NUTX
Dec 31, 2012ON ACQUISITION Converted by EDGARwiz iGAMBIT Acquires Assets and Operations of IGX-GLOBAL Acquired Operations expected to show revenue of $39 million for the year ending
iGAMBIT Acquires Assets and Operations of Acquired Operations expected to show revenue of $39 million for the year ending December 31, 2012 Press Release: iGambit Inc Mon, Jan 7, 2013 12 PM EST SMITHTOWN, NY., Jan. 7, 2013 /PRNewswire/ -- iGAMBIT, Inc. (OTCQB: IGMB), a diver
Read more →-NUTX
Apr 4, 2012SOURCE: iGambit Inc.
SOURCE: iGambit Inc. April 4, 2012 2:00 PM ET iGambit Inc. Reports more than 100% Increase in 2011 Revenue SMITHTOWN, NY-(Marketwire-April 3, 2012) - iGambit Inc. (OTCBB: IGMB), a diversified technology development and holding company reported results for the year ended Decemb
Read more →Competitive Position
How NUTX ranks across every disease it competes inCompetitive Position is a premium feature
See how NUTX ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial